Cited by 117Cytokine Signaling Pathways and InteractionsImmune cells in cancerNF-κB Signaling Pathways

The JNK Are Important for Development and Survival of Macrophages

Himes, S Roy, Sester, David P, Ravasi, Timothy, Cronau, Stephen L, Sasmono, Tedjo, Hume, David A·2006·The Journal of Immunology

Abstract

We report in this study that activation of the JNK by the growth factor, CSF-1 is critical for macrophage development, proliferation, and survival. Inhibition of JNK with two distinct classes of inhibitors, the pharmacological agent SP600125, or the peptide D-JNKI1 resulted in cell cycle inhibition with an arrest at the G2/M transition and subsequent apoptosis. JNK inhibition resulted in decreased expression of CSF-1R (c-fms) and Bcl-xL mRNA in mature macrophages and repressed CSF-1-dependent differentiation of bone marrow cells to macrophages. Macrophage sensitivity to JNK inhibitors may be linked to phosphorylation of the PU.1 transcription factor. Inhibition of JNK disrupted PU.1 binding to an element in the c-fms gene promoter and decreased promoter activity. Promoter activity could be restored by overexpression of PU.1. A comparison of expression profiles of macrophages with 22 other tissue types showed that genes that signal JNK activation downstream of tyrosine kinase receptors, such as focal adhesion kinase, Nck-interacting kinase, and Rac1 and scaffold proteins are highly expressed in macrophages relative to other tissues. This pattern of expression may underlie the novel role of JNK in macrophages.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.176.4.2219

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

1 of the 69 references couldn’t be matched to a known paper.

Research works printed but not linked: 64

  1. 2000, J. Biol. Chem., 7403
  2. 1997, Biochem. Biophys. Res. Commun., 611
  3. 1998, Curr. Opin. Cell. Biol., 205
  4. 1996, EMBO J., 2760
  5. 1991, Nature, 494
  6. 1998, Immunity, 575
  7. 1998, Science, 2092
  8. 2000, Cell, 239
  9. 1996, Oncogene, 863
  10. 2000, Mol. Cell. Biol., 8026
  11. 1994, Mol. Cell. Biol., 373
  12. 1998, J. Leukocyte Biol., 405
  13. 1996, EMBO J., 5647
  14. 1997, Mol. Reprod. Dev., 4
  15. 1988, J. Cell. Biochem., 179
  16. 1990, EMBO J., 2415
  17. 1992, Mol. Cell. Biol., 5355
  18. 1995, Mol. Cell. Biol., 693
  19. 1999, Mol. Cell. Biol., 2624
  20. 2001, J. Clin. Invest., 73
  21. 2001, Diabetes, 77
  22. 2003, Blood, 1155
  23. 1989, Nucleic Acids Res., 6419
  24. 1998, J. Biol. Chem., 6662
  25. 2001, Proc. Natl. Acad. Sci. USA, 2199
  26. 2003, Methods Mol. Biol., 111
  27. 1999, J. Biol. Chem., 15127
  28. 1995, Proc. Natl. Acad. Sci. USA, 7686
  29. 1997, Proc. Natl. Acad. Sci. USA, 4330
  30. 1994, J. Biol. Chem., 5241
  31. 2003, Cell Death Differ., 218
  32. 2001, Proc. Natl. Acad. Sci. USA, 7783
  33. 2003, Blood, 1019
  34. 1999, Genomics, 111
  35. 2003, Mol. Cell. Biol., 1896
  36. 1986, Science, 364
  37. 1996, J. Biol. Chem., 15743
  38. 2001, J. Leukocyte Biol., 812
  39. 1994, Oncogene, 121
  40. 2001, J. Biol. Chem., 17800
  41. 2000, J. Cell Biol., 741
  42. 1999, J. Cell Biol., 1461
  43. 1992, Mol. Cell. Biol., 5824
  44. 1995, Mol. Cell. Biol., 3430
  45. 2000, Biochem. J., 313
  46. 1995, Proc. Natl. Acad. Sci. USA, 6837
  47. 1991, Mol. Cell. Biol., 4466
  48. 1992, Blood, 2107
  49. 1999, Genes Dev., 607
  50. 1999, EMBO J., 188
  51. 2004, J. Biol. Chem., 5008
  52. 2001, Biochem. Biophys. Res. Commun., 173
  53. 2003, Mol. Biol. Cell., 156
  54. 1996, J. Exp. Med., 61
  55. 1998, Mol. Cell. Biol., 5148
  56. 2000, Chang Gung Med. J., 57
  57. 1997, Mol. Reprod. Dev., 11
  58. 2002, Nat. Genet., 201
  59. 2003, Hypertension, 1372
  60. 2002, Oncogene, 6488
  61. 1998, Blood, 3702
  62. 2002, Blood, 111
  63. 1996, Proc. Natl. Acad. Sci. USA, 2774
  64. 2001, J. Immunol., 5646

Cited by

Sorted by citations

Authors
Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T., & Hume, D. A.
Affiliations
  • The University of Queensland (AU)
  • Cooperative Research Centre for Chronic Inflammatory Disease, Institute for Molecular Biosciences, University of Queensland , Brisbane ,
Venue
The Journal of Immunology
Published
2006-02
Volume
176
Issue
4
Pages
2219-2228
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1582648966
Cited by
117
References
69
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 1 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 10 · 2013: 9 · 2012: 4
FWCI
4.19
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
JNK, macrophage development, macrophage survival, CSF-1, CSF-1 receptor, c-fms, Bcl-xL, apoptosis
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Bone Marrow Cells, Cell Differentiation, Cell Survival, Cells, Cultured, DNA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review